drugset / Trial / NCT03094663

Adductor Canal Block With Periarticular Injection and IPACK (ACB/PAI/IPACK) Versus Periarticular Injection (PAI)

NCT03094663

Phase 4 Completed 86 enrolled Hospital for Special Surgery, New York
RandomizedParallel-groupDouble-blindTreatment

Summary

A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Periarticular Injection (PAI)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI) - in patients undergoing total knee arthroplasty. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).

Timeline

Start
2017-02-28
Primary completion
2018-05-31
Completion
2018-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 15 ml Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Bupivacaine Other / unclassified 25 ml Other
Subject Bupivacaine Other / unclassified 30 ml Other
Comparator Dexamethasone Small molecule 2 mg Intravenous
Background Cefazolin Small molecule 500 mg Other
Background Epinephrine Other / unclassified Other
Background Methylprednisolone Other / unclassified 40 mg Other

Indications